93
Participants
Start Date
July 1, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
May 31, 2024
Flow cytometric immunophenotyping
CD155 expression by flow cytometric immunophenotyping
Complete blood count
Complete blood count with peripheral blood smear examination
Bone marrow aspiration
Bone marrow aspiration at both diagnosis and follow up of patients
Cytogenetic testing
Karyotyping or AML fluorescence in situ hybridization (FISH) panel for diagnosis and risk stratification of AML patients
FLT3-ITD using High resolution melting curve (HRM) analysis
Detection of FLT3-ITD mutation in AML patinets
South Egypt Cancer Institute, Assiut University, Asyut
Assiut University
OTHER